Ex vivo expansion potential of murine hematopoietic stem cells is a rare property only partially predicted by phenotype

Elife. 2024 Mar 6:12:RP91826. doi: 10.7554/eLife.91826.

Abstract

The scarcity of hematopoietic stem cells (HSCs) restricts their use in both clinical settings and experimental research. Here, we examined a recently developed method for expanding rigorously purified murine HSCs ex vivo. After 3 weeks of culture, only 0.1% of cells exhibited the input HSC phenotype, but these accounted for almost all functional long-term HSC activity. Input HSCs displayed varying potential for ex vivo self-renewal, with alternative outcomes revealed by single-cell multimodal RNA and ATAC sequencing profiling. While most HSC progeny offered only transient in vivo reconstitution, these cells efficiently rescued mice from lethal myeloablation. The amplification of functional HSC activity allowed for long-term multilineage engraftment in unconditioned hosts that associated with a return of HSCs to quiescence. Thereby, our findings identify several key considerations for ex vivo HSC expansion, with major implications also for assessment of normal HSC activity.

Keywords: ex vivo expansion; hematopoietic stem cell; mouse; regenerative medicine; stem cells; transplantation.

MeSH terms

  • Animals
  • Cell Division
  • Hematopoietic Stem Cells*
  • Mice
  • Phenotype
  • RNA*

Substances

  • RNA

Associated data

  • GEO/GSE234906
  • GEO/GSE197070
  • GEO/GSE61533
  • GEO/GSE175400

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.